Encompass Health (NYSE:EHC – Free Report) had its price objective hoisted by Truist Financial from $82.00 to $86.00 in a research report sent to investors on Friday, Benzinga reports. The firm currently has a buy rating on the stock.
Several other equities analysts also recently commented on the company. Royal Bank of Canada reaffirmed an outperform rating and issued a $83.00 target price on shares of Encompass Health in a research report on Friday. Mizuho upped their target price on Encompass Health from $77.00 to $82.00 and gave the company a buy rating in a research report on Friday. William Blair reaffirmed an outperform rating on shares of Encompass Health in a research report on Wednesday. Finally, Stephens reissued an overweight rating and set a $85.00 price target on shares of Encompass Health in a research report on Tuesday, January 16th. One investment analyst has rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of Buy and an average target price of $79.89.
Encompass Health Price Performance
Insider Buying and Selling at Encompass Health
In other news, CFO Douglas E. Coltharp sold 11,215 shares of the stock in a transaction on Monday, November 13th. The stock was sold at an average price of $63.39, for a total value of $710,918.85. Following the completion of the transaction, the chief financial officer now directly owns 116,293 shares in the company, valued at approximately $7,371,813.27. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.90% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the company. US Bancorp DE raised its position in Encompass Health by 66.4% during the 1st quarter. US Bancorp DE now owns 9,336 shares of the company’s stock worth $664,000 after purchasing an additional 3,725 shares during the last quarter. Cambridge Investment Research Advisors Inc. acquired a new stake in shares of Encompass Health in the 1st quarter valued at about $318,000. PNC Financial Services Group Inc. grew its stake in shares of Encompass Health by 10.5% in the 1st quarter. PNC Financial Services Group Inc. now owns 8,750 shares of the company’s stock valued at $622,000 after buying an additional 834 shares during the period. Bank of Montreal Can grew its stake in shares of Encompass Health by 1.5% in the 1st quarter. Bank of Montreal Can now owns 11,340 shares of the company’s stock valued at $806,000 after buying an additional 173 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its stake in shares of Encompass Health by 10.5% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 36,463 shares of the company’s stock valued at $2,593,000 after buying an additional 3,477 shares during the period. 92.66% of the stock is currently owned by institutional investors.
Encompass Health Company Profile
Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
- Five stocks we like better than Encompass Health
- How to Invest in Canada for Beginners
- Cloudflare results spark analysts reset: 25% upside ahead
- Investing In Automotive Stocks
- Beyond Nvidia: The hidden stars with 200% earnings growth
- Retail Stocks Investing, Explained
- 3 large caps with RSIs that scream ‘oversold’
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.